Home
Products
Learn
About
Pricing
Log In
EDIT
Asset Logo

Editas Medicine Inc.

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-18.81%
Annual Growth

5 years average annual capital growth

🌏

3
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Editas Medicine, Inc. is a genome-editing company developing potentially transformative genomic medicines to treat a broad range of serious diseases. It has developed a proprietary gene editing platform based on CRISPR technology that includes CRISPR/Cas9, CRISPR/Cas12a, engineered forms and foundational intellectual property for both CRISPR systems. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1), bound to a guide RNA molecule designed to recognize a particular DNA sequence. It is engaged in discovering, developing, manufacturing, and commercializing durable, precision in vivo gene-editing medicines for a broad class of diseases. Vivo medicines include vivo editing of hematopoietic stem cells (HSCs), liver cells and other tissues. Vivo gene editing in HSCs supports the advancement of research programs to treat non-malignant hematological diseases.

📈 Performance

Price History*

-93.38%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$1.18

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in EDIT

3

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

59 weeks

💵 Average investment amount

$2,925

Last time a customer invested in EDIT

36 days
EDIT investor breakdown
💵 Income of investors

More than 200k

33%

150k - 200k

100k - 150k

50k - 100k

67%

Less than 50k

👶 Age of investors

18 - 25

26 - 34

33%

35 - 90

67%
🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in EDIT also invest in...

CRISPR Therapeutics AG

CRSP

🙌 Performance (5Yr p.a)

-2.65%

📊 Share price

$34.19 USD
Find Out More

🙌 Performance (5Yr p.a)

325.64%

📊 Share price

$110.42 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

540.55%

📊 Share price

$282.76 USD

🙌 Performance (5Yr p.a)

4.92%

📊 Share price

$11.55 USD

🙌 Performance (5Yr p.a)

1.41%

📊 Share price

$147.76 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

12.42%

📊 Share price

$35.90 USD

📈 HIGH PRICE GROWTH

📊 Share price

$24.44 USD
Compare
Add to watchlist